I, FELICITY MCNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated               26                  July 2011

Part 1   Preliminary

1 Name of Determination

 (1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2011(No.8).

 (2) This Determination may also be cited as PB 51 of 2011.

2 Commencement

  This Determination commences on 1 August 2011.

3 Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

  Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1    Amendments

(Section 3)

[1] Schedule 1, after item dealing with Disopyramide

Omit

 Dolasetron

[2] Schedule 1, after item dealing with Everolimus

Omit

 Exemestane

[3] Schedule 1, after item dealing with Fenofibrate

Omit

 Fentanyl

[4] Schedule 2, after item dealing with Etoposide

Insert

 Exemestane

[5] Schedule 2, after item dealing with Felodipine

Insert

 Fentanyl

Note

1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.